Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Mary R. Rensel, MD, is a Staff Neurologist in Neuroimmunology at Cleveland Clinic's Mellen Center for Multiple Sclerosis Treatment and Research, where she was appointed in 1998. Dr. Rensel is a Diplomate of the American Board of Psychiatry and Neurology and a member of the American Academy of Neurology.
She is also Board Certified in Integrative Holistic Medicine. She is a Clinical Associate Professor at the Cleveland Clinic Learner College of Medicine where she serves as an instructor for the medical students. She is a coach and mentor at Cleveland Clinic.
Dr. Rensel has served on the National Multiple Sclerosis Society Pediatric MS Advisory Board and is currently serving on the International Pediatric MS study Group. Since 2001, she has been a participant on the Bureau for Children with Medical Handicaps. Dr. Rensel received the Clinical Neurology Award from the Medical College of Ohio in 1992. She has been named one of the Best Doctors per the Cleveland Magazines since 2010.
Dr. Rensel has had articles and abstracts published in peer-reviewed medical journals and has written chapters: "Differential Diagnosis of MS and Clues to Misdiagnosis," in the book entitled Multiple Sclerosis: Diagnosis, Medical Management and Rehabilitation as well as "General Health and Wellness in MS" in the book entitled Multiple Sclerosis and Related Disorders.
Adult Multiple Sclerosis, Pediatric Multiple Sclerosis
Wellness for MS patients
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland
Clinic's procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. The Cleveland Clinic requires its doctors to approve the public disclosures of their scientific collaborations with industry. As of 8/31/2014 the review process regarding Dr. Rensel's disclosure had not been completed. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.